Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
crv431 (4 trials)
Fatty Liver (Phase 2)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Trials (4 total)
Trial APIs (1 total)